BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 17924575)

  • 1. Multiple sclerosis and Alzheimer's disease.
    Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
    Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.
    Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P
    Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.
    Kooi EJ; Geurts JJ; van Horssen J; Bø L; van der Valk P
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):1021-8. PubMed ID: 19680141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
    Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
    Kutzelnigg A; Lucchinetti CF; Stadelmann C; Brück W; Rauschka H; Bergmann M; Schmidbauer M; Parisi JE; Lassmann H
    Brain; 2005 Nov; 128(Pt 11):2705-12. PubMed ID: 16230320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome.
    Head E; Azizeh BY; Lott IT; Tenner AJ; Cotman CW; Cribbs DH
    Neurobiol Dis; 2001 Apr; 8(2):252-65. PubMed ID: 11300721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression stage senile plaques in the natural course of Alzheimer's disease.
    Oide T; Kinoshita T; Arima K
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of isoaspartic acid in beta-amyloid plaques indicates plaque age.
    Fonseca MI; Head E; Velazquez P; Cotman CW; Tenner AJ
    Exp Neurol; 1999 Jun; 157(2):277-88. PubMed ID: 10364440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison.
    Jeynes B; Provias J
    Acta Neuropathol; 2006 Oct; 112(4):417-27. PubMed ID: 16830133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes is related to cerebral infarction but not to AD pathology in older persons.
    Arvanitakis Z; Schneider JA; Wilson RS; Li Y; Arnold SE; Wang Z; Bennett DA
    Neurology; 2006 Dec; 67(11):1960-5. PubMed ID: 17159101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration.
    Lue LF; Brachova L; Civin WH; Rogers J
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1083-8. PubMed ID: 8858005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat microglia exhibit increased density on Alzheimer's plaques in vitro.
    Joshi SN; Crutcher KA
    Exp Neurol; 1998 Jan; 149(1):42-50. PubMed ID: 9454613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial pathology in Down syndrome.
    Xue QS; Streit WJ
    Acta Neuropathol; 2011 Oct; 122(4):455-66. PubMed ID: 21847625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
    Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
    Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI; Geula C; Mesulam MM
    Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
    Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
    Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotactic signaling, microglia, and Alzheimer's disease senile plaques: is there a connection?
    Luca M; Chavez-Ross A; Edelstein-Keshet L; Mogilner A
    Bull Math Biol; 2003 Jul; 65(4):693-730. PubMed ID: 12875339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex.
    Hoozemans JJ; Veerhuis R; Rozemuller AJ; Arendt T; Eikelenboom P
    Neurobiol Dis; 2004 Apr; 15(3):492-9. PubMed ID: 15056456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia as a potential bridge between the amyloid beta-peptide and tau.
    Kitazawa M; Yamasaki TR; LaFerla FM
    Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.